NEW YORK, April 3, 2003 (PRIMEZONE) -- A jury in Manhattan returned a verdict in the amount of $2 million against Warner-Lambert, a wholly owned subsidiary of Pfizer, Inc. (NYSE:PFE), on behalf of plaintiff, Concepcion Morgado. Mrs. Morgado, a Type 2 diabetic, was injured as a result of taking the Warner-Lambert diabetes drug, Rezulin. Rezulin was withdrawn from the market in March of 2000. The jury unanimously found by "clear and convincing" evidence that Warner-Lambert misrepresented or omitted material information about Rezulin to physicians, including Mrs. Morgado's physician, which was a substantial factor in causing Mrs. Morgado's injury.
The jury further found that Warner-Lambert showed conscious indifference and utter disregard for the safety and rights of others. The trial team representing Mrs. Morgado is: Christopher A. Seeger, David R. Buchanan, Stuart P. Slotnick, Troy A. Rafferty, and Christopher V. Tisi.